Breast Cancer Research at ESMO 2021

Dr. Brian Wojciechowski practices medical oncology in Delaware County, Pennsylvania at Riddle, Taylor, and Crozer hospitals and also serves as Breastcancer.org's medical adviser. A native of South Philadelphia, he trained at Temple University School of Medicine and Lankenau Medical Center. Dr. Wojciechowski is a sought-after speaker on the topics of medical ethics and the biology of cancer. Dr. Wojciechowski joined us to talk about some of the most notable research at the European Society for Medical Oncology Congress 2021. Listen to the episode to hear Dr. Wojciechowski explain: what an antibody-drug conjugate is results from the DESTINY-Breast03 study, showing Enhertu more than doubled the 12-month progression-free survival rate compared to Kadcyla in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated results from the BrighTNess study, showing adding carboplatin to chemotherapy before surgery improves progression-free survival. Running time: 14:09

There are no comments yet.

Please log in to write the first comment.